Alivus Life Sciences Limited (NSE: GLS)
India
· Delayed Price · Currency is INR 958.40
-35.50 (-3.57%)
Dec 24, 2024, 3:30 PM IST
Alivus Life Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 24, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2018 |
| Market Capitalization | 117,435 | 95,161 | 48,141 | 56,215 | - | - | Upgrade
|
| Market Cap Growth | 71.12% | 97.67% | -14.36% | - | - | - | Upgrade
|
| Enterprise Value | 113,132 | 90,913 | 44,570 | 52,405 | - | - | Upgrade
|
| Last Close Price | 958.40 | 776.65 | 379.66 | 410.70 | - | - | Upgrade
|
| PE Ratio | 27.81 | 20.21 | 10.31 | 13.43 | - | - | Upgrade
|
| Forward PE | 21.64 | 16.54 | 9.96 | 11.60 | - | - | Upgrade
|
| PS Ratio | 5.33 | 4.17 | 2.23 | 2.65 | - | - | Upgrade
|
| PB Ratio | 4.63 | 4.08 | 2.25 | 2.74 | - | - | Upgrade
|
| P/TBV Ratio | 5.14 | 4.11 | 2.27 | 2.75 | - | - | Upgrade
|
| P/FCF Ratio | 44.32 | 33.44 | 33.62 | 12.08 | - | - | Upgrade
|
| P/OCF Ratio | 31.08 | 23.01 | 15.73 | 9.41 | - | - | Upgrade
|
| PEG Ratio | 1.40 | 1.12 | 0.98 | 0.72 | - | - | Upgrade
|
| EV/Sales Ratio | 5.13 | 3.98 | 2.06 | 2.47 | - | - | Upgrade
|
| EV/EBITDA Ratio | 18.68 | 13.59 | 6.97 | 8.53 | - | - | Upgrade
|
| EV/EBIT Ratio | 20.50 | 14.61 | 7.42 | 9.05 | - | - | Upgrade
|
| EV/FCF Ratio | 42.69 | 31.95 | 31.12 | 11.26 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 1.24 | 2.64 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.03 | 0.03 | 0.00 | 1.57 | 2.24 | Upgrade
|
| Debt / FCF Ratio | 0.06 | 0.06 | 0.14 | 0.01 | 2.91 | 7.36 | Upgrade
|
| Asset Turnover | 0.73 | 0.82 | 0.84 | 0.95 | 1.01 | 0.96 | Upgrade
|
| Inventory Turnover | 1.52 | 1.64 | 1.87 | 2.07 | 2.02 | 1.76 | Upgrade
|
| Quick Ratio | 2.81 | 2.64 | 2.34 | 3.10 | 0.66 | 0.52 | Upgrade
|
| Current Ratio | 4.52 | 4.37 | 3.73 | 4.60 | 1.15 | 0.89 | Upgrade
|
| Return on Equity (ROE) | 17.18% | 21.07% | 22.28% | 29.83% | 60.91% | 127.84% | Upgrade
|
| Return on Assets (ROA) | 11.43% | 14.01% | 14.52% | 16.20% | 18.86% | 17.33% | Upgrade
|
| Return on Capital (ROIC) | 13.90% | 17.25% | 17.82% | 19.33% | 22.32% | 20.46% | Upgrade
|
| Earnings Yield | 3.60% | 4.95% | 9.70% | 7.45% | - | - | Upgrade
|
| FCF Yield | 2.26% | 2.99% | 2.97% | 8.28% | - | - | Upgrade
|
| Dividend Yield | 2.35% | 2.90% | 5.53% | 5.11% | - | - | Upgrade
|
| Payout Ratio | 65.10% | 58.55% | 82.64% | 30.73% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.28% | -0.13% | -4.25% | -9.02% | - | -35.79% | Upgrade
|
| Total Shareholder Return | 2.07% | 2.77% | 1.28% | -3.91% | - | -35.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.